Gene · 445
Papers3,531
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,531
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mutation Analysis of Autosomal-Dominant Polycystic Kidney Disease Patients. | Genes (Basel) | 2023 | 36833371 | PubTator, text mining | PubMed |
| Prognostic Significance of Amino Acid Metabolism-Related Genes in Prostate Cancer Retrieved by Machine Learning. | Cancers (Basel) | 2023 | 36831650 | PubTator, text mining | PubMed |
| Next generation oncolytic viruses expressing PADI1 and TIMP2 exhibit anti-tumor activity against melanoma in nude and humanized mouse models. | Mol Ther Oncolytics | 2023 | 36816748 | PubTator, text mining | PubMed |
| Mathematical model of mechanobiology of acute and repeated synaptic injury and systemic biomarker kinetics. | Front Cell Neurosci | 2023 | 36814869 | PubTator, text mining | PubMed |
| Deciphering the underlying mechanism of liver diseases through utilization of multicellular hepatic spheroid models. | BMB Rep | 2023 | 36814078 | PubTator, text mining | PubMed |
| Genome-wide association study identifies WWC2 as a possible locus associated with persistent pulmonary hypertension of the newborn in the Thai population. | Transl Pediatr | 2023 | 36798934 | PubTator, text mining | PubMed |
| Influenced tumor microenvironment and tumor immunity by amino acids. | Front Immunol | 2023 | 36798123 | PubTator, text mining | PubMed |
| aRgus: Multilevel visualization of non-synonymous single nucleotide variants & advanced pathogenicity score modeling for genetic vulnerability assessment. | Comput Struct Biotechnol J | 2023 | 36789265 | PubTator, text mining | PubMed |
| Novel insight into metabolic reprogrammming in cancer radioresistance: A promising therapeutic target in radiotherapy. | Int J Biol Sci | 2023 | 36778122 | PubTator, text mining | PubMed |
| Supplementation with Nitric Oxide Precursors for Strength Performance: A Review of the Current Literature. | Nutrients | 2023 | 36771366 | PubTator, text mining | PubMed |
| SAV-Pred: A Freely Available Web Application for the Prediction of Pathogenic Amino Acid Substitutions for Monogenic Hereditary Diseases Studied in Newborn Screening. | Int J Mol Sci | 2023 | 36768784 | PubTator, text mining | PubMed |
| Amino Acid-Metabolizing Enzymes in Advanced High-Grade Serous Ovarian Cancer Patients: Value of Ascites as Biomarker Source and Role for IL4I1 and IDO1. | Cancers (Basel) | 2023 | 36765849 | PubTator, text mining | PubMed |
| Arginine transportation mechanism through cationic amino acid transporter 1: insights from molecular dynamics studies. | J Biomol Struct Dyn | 2023 | 36762692 | PubTator, text mining | PubMed |
| Cell cycle-dependent palmitoylation of protocadherin 7 by ZDHHC5 promotes successful cytokinesis. | J Cell Sci | 2023 | 36762613 | PubTator, text mining | PubMed |
| Metabolic reprogramming in colorectal cancer: regulatory networks and therapy. | Cell Biosci | 2023 | 36755301 | PubTator, text mining | PubMed |
| Single-cell profiling of alveolar rhabdomyosarcoma reveals RAS pathway inhibitors as cell-fate hijackers with therapeutic relevance. | Sci Adv | 2023 | 36753540 | PubTator, text mining | PubMed |
| A review on the role of long non-coding RNA and microRNA network in clear cell renal cell carcinoma and its tumor microenvironment. | Cancer Cell Int | 2023 | 36732762 | PubTator, text mining | PubMed |
| Neuroimaging findings of inborn errors of metabolism: urea cycle disorders, aminoacidopathies, and organic acidopathies. | Jpn J Radiol | 2023 | 36729192 | PubTator, text mining | PubMed |
| Metabolism-associated molecular classification of uterine corpus endometrial carcinoma. | Front Genet | 2023 | 36726804 | PubTator, text mining | PubMed |
| Impact of small molecule-mediated inhibition of ammonia detoxification on lung malignancies and liver metabolism. | Cancer Commun (Lond) | 2023 | 36708276 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/445/papers?page=26